SSc fibroblasts expressed mRNA for P2X3, P2X4, P2X7, P2Y1, P2Y2, P2Y4, and P2Y6, suggesting a possible therapeutic role for P2R antagonists in SSc patients via modulation of fibroblast function. This evidence concerns the gene P2RX3 and systemic sclerosis.